Browsing by Author Tim R. Cressey

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 28 to 47 of 73 < previous   next >
Issue DateTitleAuthor(s)
1-Dec-2012Once- versus twice-daily lopinavir/ritonavir tablets in virologically suppressed, HIV-infected, treatment-experienced children: Comparative pharmacokinetics and virological outcome after switching to once-daily lopinavir/ritonavirKulkanya Chokephaibulkit; Maneeratn Nuntarukchaikul; Wanatpreeya Phongsamart; Orasri Wittawatmongkol; Keswadee Lapphra; Nirun Vanprapar; Tim R. Cressey
1-Jan-2017Optimization of the strength of the efavirenz/lamivudine/abacavir fixed-dose combination for paediatric patientsNaïm Bouazza; Tim R. Cressey; Frantz Foissac; Andrzej Bienczak; Paolo Denti; Helen McIlleron; David Burger; Martina Penazzato; Marc Lallemant; Edmund V. Capparelli; Jean Marc Treluyer; Saïk Urien
15-Aug-2018Optimizing Clinical Trial Design to Maximize Evidence Generation in Pediatric HIVDeborah Ford; Rebecca Turner; Anna Turkova; Martina Penazzato; Victor Musiime; Mutsa Bwakura-Dangarembizi; Avy Violari; Chishala Chabala; Thanyawee Puthanakit; Tavitiya Sudjaritruk; Tim R. Cressey; Marc Lallemant; Diana M. Gibb
1-Aug-2019Optimizing Pediatric Dosing Recommendations and Treatment Management of Antiretroviral Drugs Using Therapeutic Drug Monitoring Data in Children Living With HIVHylke Waalewijn; Anna Turkova; Natella Rakhmanina; Tim R. Cressey; Martina Penazzato; Angela Colbers; David M. Burger
1-Dec-2012Pharmacogenetic markers of CYP2B6 associated with efavirenz plasma concentrations in HIV-1 infected Thai adultsChonlaphat Sukasem; Tim R. Cressey; Pattamawan Prapaithong; Yardpiroon Tawon; Ekawat Pasomsub; Chutatip Srichunrusami; Thawinee Jantararoungtong; Marc Lallement; Wasun Chantratita
12-Jan-2010Pharmacogenetics and the prevention of mother-to-child transmission of HIVTim R. Cressey; Marc Lallemant
9-Oct-2015Pharmacokinetic interactions between artesunate-mefloquine and ritonavir-boosted lopinavir in healthy Thai adultsSiwalee Rattanapunya; Tim R. Cressey; Ronnatrai Rueangweerayut; Yardpiroon Tawon; Panida Kongjam; Kesara Na-Bangchang
1-Dec-2015Pharmacokinetic interactions between quinine and lopinavir/ritonavir in healthy Thai adultsSiwalee Rattanapunya; Tim R. Cressey; Ronnatrai Rueangweerayut; Yardpiroon Tawon; Panida Kongjam; Kesara Na-Bangchang
1-Oct-2012Pharmacokinetic optimization of antiretroviral therapy in pregnancyKajal Buckoreelall; Tim R. Cressey; Jennifer R. King
19-Dec-2011Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected childrenKulkanya Chokephaibulkit; Tim R. Cressey; Edmund Capparelli; Virat Sirisanthana; Petronella Muresan; Suchat Hongsiriwon; Chaiwat Ngampiyaskul; Chanin Limwongse; Orasri Wittawatmongkol; Linda Aurpibul; Bill Kabat; Mari Pat Toye; Mary Elizabeth Smith; Achara Eksaengsri; Kenneth McIntosh; Ram Yogev
10-Sep-2010Pharmacokinetics and virologic response of zidovudine/lopinavir/ritonavir initiated during the third trimester of pregnancyTim R. Cressey; Gonzague Jourdain; Boonsong Rawangban; Supang Varadisai; Rucha Kongpanichkul; Prapan Sabsanong; Prapap Yuthavisuthi; Somnuk Chirayus; Nicole Ngo-Giang-Huong; Nipunporn Voramongkol; Somsak Pattarakulwanich; Marc Lallemant
1-May-2013Pharmacokinetics of an increased atazanavir dose with and without tenofovir during the third trimester of pregnancyRegis Kreitchmann; Brookie M. Best; Jiajia Wang; Alice Stek; Edmund Caparelli; D. Heather Watts; Elizabeth Smith; David E. Shapiro; Steve Rossi; Sandra K. Burchett; Elizabeth Hawkins; Mark Byroads; Tim R. Cressey; Mark Mirochnick
1-Sep-2017Pharmacokinetics of darunavir/ritonavir with etravirine both twice daily in human immunodeficiency virus-infected adolescents and young adultsTim R. Cressey; Ram Yogev; Andrew Wiznia; Rohan Hazra; Patrick Jean-Philippe; Bobbie Graham; Amy Gonzalez; Paula Britto; Vincent J. Carey; Courtney V. Fletcher; Edward P. Acosta
1-Apr-2012Pharmacokinetics of nevirapine in HIV and tuberculosis-coinfected children receiving antiretroviral fixed-dose combination tablets while receiving rifampicin-containing tuberculosis treatment and after rifampicin discontinuationWasana Prasitsuebsai; Tim R. Cressey; Edmund Capparelli; Nirun Vanprapar; Keswadee Lapphra; Kulkanya Chokephaibulkit
23-Sep-2005Pharmacokinetics of nevirapine in HIV-infected children receiving an adult fixed-dose combination of stavudine, lamivudine and nevirapineKulkanya Chokephaibulkit; Nottasorn Plipat; Tim R. Cressey; Koen Frederix; Wanatpreeya Phongsamart; Edmund Capparelli; Teera Kolladarungkri; Nirun Vanprapar
1-Jan-2015Pharmacokinetics of once versus twice daily darunavir in pregnant HIV-infected womenAlice Stek; Brookie M. Best; Jiajia Wang; Edmund V. Capparelli; Sandra K. Burchett; Regis Kreitchmann; Kittipong Rungruengthanakit; Tim R. Cressey; Lynne M. Mofenson; Elizabeth Smith; David Shapiro; Mark Mirochnick
10-Jun-2016Pharmacokinetics of once-daily darunavir/ ritonavir with and without etravirine in human immunodeficiency virus-infected children, adolescents, and young adultsKajal B. Larson; Tim R. Cressey; Ram Yogev; Andrew Wiznia; Rohan Hazra; Patrick Jean-Philippe; Bobbie Graham; Amy Gonzalez; Paula Britto; Vincent J. Carey; Edward P. Acosta
1-Mar-2014Pharmacokinetics of pediatric lopinavir/ritonavir tablets in children when administered twice daily according to FDA weight bandsDiane E.T. Bastiaans; Silvia Forcat; Hermione Lyall; Tim R. Cressey; Rawiwan Hansudewechakul; Suparat Kanjanavanit; Antoni Noguera-Julian; Christoph Konigs; Jamie R.J. Inshaw; Suwalai Chalermpantmetagul; Yacine Saidi; Alexandra Compagnucci; Lynda M. Harper; Carlo Giaquinto; Angela P.H. Colbers; David M. Burger
1-Jan-2018Pharmacokinetics of rilpivirine and 24-week outcomes after switching from efavirenz in virologically suppressed HIV-1-infected adolescentsWatsamon Jantarabenjakul; Suvaporn Anugulruengkitt; Naruporn Kasipong; Narukjaporn Thammajaruk; Jiratchaya Sophonphan; Torsak Bunupuradah; Tim R. Cressey; Angela Colbers; David M. Burger; Wanatpreeya Phongsamart; Thanyawee Puthanakit; Chitsanu Pancharoen
1-Jul-2016Pharmacokinetics of Rilpivirine in HIV-Infected Pregnant WomenAnna H. Tran; Brookie M. Best; Alice Stek; Jiajia Wang; Edmund V. Capparelli; Sandra K. Burchett; Regis Kreitchmann; Kittipong Rungruengthanakit; Kathleen George; Tim R. Cressey; Nahida Chakhtoura; Elizabeth Smith; David E. Shapiro; Mark Mirochnick; Shelley Buschur; Chivon Jackson; Mary Paul; Donna McGregor; Ram Yogev; Rohit Kalra; Claudia Florez; Patricia Bryan; Monica Stone; Andrew D. Hull; Mary Caffery; Stephen A. Spector; Joan Wilson; Julieta Giner; Margaret A. Donnelly; Ellen R. Cooper; Debra A. McLaud; Lisa F. Tucker; Jane Hitti; Amanda Robson-Nuss; Ann J. Melvin; Margaret A. Keller; Michael A. Bolaris; Judy Hayes; Françoise Kamer; La Shonda Spencer; James Homans; Torri Metz; Jenna Wallace; Alisa Katai; Mariam Aziz; Maureen McNichols; Julie Schmidt; Diane Wara; Kristinalisa Maka; Deborah Cohan; Audra Deveikis; Jagmohan Batra; Janielle Jackson Alvarez; Michele Carter; Jaime Deville; Carla Janzen; Jenny Gutierrez; Martha Cavallo; Murli Purswani; Katherine M. Knapp; Nina Sublette; Thomas Wride